D. Breuer

发表

Biochemical Characterization and Subcellular Localization of the Mouse Retinitis Pigmentosa GTPase Regulator (mRpgr)*

A. Swaroop, A. Rehemtulla, D. Yan, 1998, The Journal of Biological Chemistry.

Clinical and immunohistochemical evidence for an X linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in association with an RPGR mutation

A. Swaroop, C. Morton, D. Breuer, 2003, Journal of medical genetics.

Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2

William L. Smith, D. Breuer, M. Lagarde, 1995, The Journal of Biological Chemistry.

Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.

D. Breuer, T. Hla, C. Funk, 1994, The Journal of pharmacology and experimental therapeutics.

Mutations in a BTB-Kelch protein, KLHL7, cause autosomal-dominant retinitis pigmentosa.

G. Abecasis, A. Swaroop, D. Breuer, 2009, American journal of human genetics.

A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa.

P. Sieving, S. Jacobson, A. Swaroop, 2002, American journal of human genetics.

Retinal histopathology of an XLRP carrier with a mutation in the RPGR exon ORF15.

A. Milam, G. Aguirre, A. Swaroop, 2002, Experimental eye research.

Clinical studies of X-linked retinitis pigmentosa in three Swedish families with newly identified mutations in the RP2 and RPGR-ORF15 genes

A. Swaroop, D. Breuer, B. Yashar, 2003, Ophthalmic genetics.

X-Linked Retinitis Pigmentosa: Current Status

P. Sieving, S. Jacobson, A. Swaroop, 2001 .

DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE H SYNTHASES-1 AND -2 BY ASPIRIN AND OTHER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS1

D. Breuer, D. Dewitt, M. Lecomte, 1995, European Journal of Medicinal Chemistry.